Recent scientific advancements have shed new light on the implications of PIK3CA mutations in cancer treatment, prompting significant interest in developing targeted therapies to enhance drug efficacy while mitigating adverse effects. The PIK3CA gene, which encodes the p110α subunit of
Key players in the pharmaceutical landscape, Summit Therapeutics and Pfizer, are embarking on a noteworthy collaboration to test out Summit’s experimental immunotherapy, ivonescimab, combined with Pfizer’s sophisticated antibody-drug conjugates (ADCs) in upcoming clinical trials targeting specific s
Nanomedicine has made remarkable strides since the 1950s, revolutionizing the way drugs are delivered within the body. A recent breakthrough by scientists at ETH Zürich leverages sound waves to control microscopic flower-like zinc oxide particles for targeted drug delivery, marking a significant
Recent advancements in healthcare are uncovering surprising new uses for existing medications, and one prominent example is Ozempic (semaglutide). Originally hailed for its effectiveness in treating diabetes and aiding in weight loss, Ozempic is now being investigated for its potential to address
Laboratory research has always been at the forefront of scientific innovation, driving breakthroughs in medicine, materials science, and more. Recently, the integration of automation and artificial intelligence (AI) has begun to revolutionize how research is conducted, offering unprecedented
The intersection of biotechnology and artificial intelligence (AI) is poised to address the inefficiencies and ethical concerns plaguing the current drug development process. One of the most promising innovations in this field is the Bio-AI clinical prediction platform developed by Quris-AI, which
